Iron metabolism markers in renal anemia.

Iron metabolism markers in renal anemia. - Iron metabolism markers in renal anemia.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220232

Enrollment

Registered

2015-12-10

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure (HD patients)

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis (HD) patients who do not use iron or erythropoietin (Epo) .

Exclusion criteria

Exclusion criteria: Malignant disease,Liver citthosis,Heart failure

Design outcomes

Primary

Measure	Time frame
HPC25,8OHdG,sTfR,hs-CRP,VitB12,VitC,folic acid,carnitine,ceruloplasmin,Cu,IL-6,ERF,FGF23,NTBI,EPO,WBC,RBC,Hb,Plt,MCV,MCH,MCHC,Plt,Ret,hypoHe,RetHe,Na,K,Cl,BUN,CRE,UA,IP,Ca,Mg,Fe,UIBC,Tf,Ferritin,AST,ALT,ALP,LDH,Alb,TP,Zn,B2MG,CRP,intPTH	—

Countries

Japan

Contacts

Public ContactShigeru Miyazaki

Shinraku-en Hospital

byori@shinrakuen.com+81-25-260-8200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026